Skip to content
10-Q

Quarterly Report

RESOLUTE ONCOLOGY INC

0001038838-13-000323

← back to feed
Filed
Aug 19, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Aug 9, 2013 41.39M sh
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$3.44M
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$2.3M
Cash And Equivalents Q2 2013 · Jun 30, 2013 $114.05K
Cash And Equivalents Q2 2013 · Dec 31, 2012 $1.08M
Stockholders Equity Q2 2013 · Jun 30, 2013 −$33.61K
Stockholders Equity Q2 2013 · Dec 31, 2012 −$71.92K
Current Liabilities Q2 2013 · Jun 30, 2013 $1.29M
Current Liabilities Q2 2013 · Dec 31, 2012 $1.79M
Total Liabilities Q2 2013 · Jun 30, 2013 $1.29M
Total Liabilities Q2 2013 · Dec 31, 2012 $1.79M
Current Assets Q2 2013 · Jun 30, 2013 $148.31K
Current Assets Q2 2013 · Dec 31, 2012 $1.72M
Total Assets Q2 2013 · Jun 30, 2013 $1.25M
Total Assets Q2 2013 · Dec 31, 2012 $1.72M
Net Income Q2 2013 · Jun 30, 2013 −$2.1M
Net Income Q2 2013 · Jun 30, 2013 −$2.3M
Net Income Q2 2013 · Jun 30, 2013 −$2.4M
Operating Income Q2 2013 · Jun 30, 2013 −$2.1M
Operating Income Q2 2013 · Jun 30, 2013 −$2.3M
Operating Income Q2 2013 · Jun 30, 2013 −$2.4M
Gross Profit Q2 2013 · Jun 30, 2013 $21.91K
Gross Profit Q2 2013 · Jun 30, 2013 $21.91K
Gross Profit Q2 2013 · Jun 30, 2013 $21.91K
Cost Of Revenue Q2 2013 · Jun 30, 2013 $40.29K
Cost Of Revenue Q2 2013 · Jun 30, 2013 $40.29K
Cost Of Revenue Q2 2013 · Jun 30, 2013 $40.29K
Revenue Q2 2013 · Jun 30, 2013 $62.2K
Revenue Q2 2013 · Jun 30, 2013 $62.2K
Revenue Q2 2013 · Jun 30, 2013 $62.2K